Study types
- preprint 26
- article 24
- book-chapter 2
- other 2
- review 2
Condition tags
- endometriosis 52
- chronic_pelvic_pain 10
- adenomyosis 2
- dysmenorrhea 2
- bladder_endometriosis 1
- endometrioma 1
- die_deep_infiltrating 1
- dyspareunia 1
Top journals
Frequent coauthors
- Ted T.M. Lee 35
- Esther Elishaev 33
- Anda M Vlad 32
- Suketu M Mansuria 28
- Robert P. Edwards 27
- Gina Mantia-Smaldone 26
- Xin Huang 26
- Swati Suryawanshi 26
- Raluca A. Budiu 26
- George C. Tseng 19
Endometriosis (EM) is a debilitating disease involving the growth of endometrial glands and stroma outside the uterus. To further our understanding of epigenomic dysregulation in EM and search for disease biomarkers, we performed a comprehe…
Objective: The objective of this study is to determine whether patients who are diagnosed with ovarian endometrioma(s) on imaging undergo fewer total surgeries for treatment of their endometrioma and endometriosis if the initial surgery is …
INTRODUCTION: Definitive surgical management of severe endometriosis involves excision with hysterectomy and bilateral salpingo-oophorectomy (BSO). Women who are less than 50 years old at the time of BSO have an increased morbidity, includi…
Supplementary figures and table
AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …
AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …
AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …
AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …
AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…
AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…
Supplementary figures and table
Supplementary figures and table
PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…
PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…
Supplementary Materials and Methods
Supplementary Materials and Methods
PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…
PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…
Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons
Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons
Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression
Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression
Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity